Wikidata

(Q64725833)

English

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)

clinical trial

In more languages

Statements

title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) In Patients With Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Non- Carriers. (English)
0 references
country
Austria
0 references
Canada
0 references
Germany
0 references
start time
December 2007
0 references
end time
June 2012
0 references
number of participants
1,331
0 references
research site
Georgetown University
0 references
Mayo Clinic
0 references
Compass Research
0 references
Roskamp Institute
0 references
Meridien Research
0 references
University of Kentucky
0 references
University of Maryland
0 references
McLean Hospital
0 references
University of Michigan
0 references
Saint Louis University
0 references
Wake Forest University
0 references
Ohio State University
0 references
Lehigh Valley Hospital
0 references
Drexel University
0 references
Rhode Island Hospital
0 references
Butler Hospital
0 references
Texas Neurology
0 references
University of Virginia
0 references
minimum age
50 year
0 references
maximum age
88 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64725833&oldid=1858027633"